<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/4BE935D8-0777-477A-99EC-B73C5466D452" ns1:id="4BE935D8-0777-477A-99EC-B73C5466D452"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/DDD8A7D1-50EE-48A4-B5EA-BB1351B3F707" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/45A26948-EFC2-4518-A923-D8F9F743E6DB" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/9531A3B9-D6E2-4FB6-B3B7-D2B980EEC40E" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/DCC16868-A224-4340-BBD6-46B06A61F0F6" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/45A26948-EFC2-4518-A923-D8F9F743E6DB" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/B5C86DB8-4736-48A8-87D1-F9EB2A9CDE39" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2019-03-31T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/151CA235-8394-4E67-97DA-AEEC80190128" ns1:rel="FUND" ns1:start="2017-03-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">102782</ns2:identifier></ns2:identifiers><ns2:title>Innovative Manufacture of Innovative Antimicrobial Medical Devices (IMNAD)</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Collaborative R&amp;D</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>The project is a collaboration between a global market leader, two innovative UK SMEs and a leading University to develop an advanced manufacturing process to produce a medical device with antimicrobial properties in order to address the challenge of Hospital Acquired Infections, which cost the NHS &amp;pound;2bn per annum. The project uses the 'Design for Excellence' principles to create a novel combination of advanced fabrication techniques and to develop an efficient mass production process for novel antimicrobial materials.</ns2:abstractText></ns2:project>